ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 117 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,912,393 | -22.6% | 457,654 | +0.4% | 0.02% | -20.8% |
| Q2 2022 | $12,804,360 | +4.0% | 455,684 | +70.8% | 0.02% | +41.2% |
| Q1 2022 | $12,309,753 | +9.8% | 266,786 | +100.0% | 0.02% | -41.4% |
| Q4 2021 | $11,213,000 | +27.7% | 133,392 | +1.2% | 0.03% | +16.0% |
| Q3 2021 | $8,783,000 | -35.0% | 131,801 | -48.1% | 0.02% | +31.6% |
| Q2 2021 | $13,506,000 | +89.8% | 253,890 | +54.8% | 0.02% | -13.6% |
| Q1 2021 | $7,116,000 | -14.9% | 164,012 | +1.9% | 0.02% | -15.4% |
| Q4 2020 | $8,361,000 | +63.9% | 160,970 | +3.1% | 0.03% | +44.4% |
| Q3 2020 | $5,102,000 | -50.2% | 156,087 | -26.8% | 0.02% | -10.0% |
| Q2 2020 | $10,242,000 | – | 213,286 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 1,824,583 | $39,520,000 | 14.33% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,301,771 | $49,857,000 | 4.79% |
| Matrix Capital Management Company, LP | 9,199,973 | $199,271,000 | 3.81% |
| Integral Health Asset Management, LLC | 550,000 | $11,913,000 | 2.31% |
| Avidity Partners Management LP | 4,223,100 | $91,472,000 | 1.86% |
| Affinity Asset Advisors, LLC | 170,000 | $3,682,000 | 1.03% |
| Eventide Asset Management | 1,861,000 | $40,309,000 | 0.79% |
| Sofinnova Investments, Inc. | 583,357 | $12,636,000 | 0.74% |
| Nicholas Investment Partners, LP | 158,704 | $3,438,000 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 60,000 | $1,300,000 | 0.26% |